Splice Bio
Last verified 2026-04-30. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $215.0Mattributed |
|---|---|
| Latest round | series-b, $135.0M, 2025-06-01attributed |
| Founded | 2021 |
| Headquarters | Barcelona, Spain |
| Industry | bio |
| Stage | series-b+ |
| Website | splicebio.com |
Genetic medicine company using engineered inteins to overcome gene delivery size limitations for rare diseases
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-06-01 | series-b | $135.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $135.0M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $215.0M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | splicebio.com, read 2026-04-30 |
| Description | self-reported | splicebio.com, read 2026-04-30 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.